• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    medical-device-investing

    Digirad Corporation Reports Financial Results for the Fourth Quarter and Twelve Months Ended December 31, 2017

    Gabrielle Lakusta
    Feb. 23, 2018 09:46AM PST
    Medical Device Investing

    Digirad (Nasdaq:DRAD) reported its financial results for the fourth quarter and twelve months ended December 31, 2017. As quoted in the press release: Net loss for the fourth quarter was $22.0 million, or $1.10 net loss per diluted share, compared to net income of $2.0 million, or $0.10 net income per diluted share in the …

    Digirad (Nasdaq:DRAD) reported its financial results for the fourth quarter and twelve months ended December 31, 2017.

    As quoted in the press release:

    Net loss for the fourth quarter was $22.0 million, or $1.10 net loss per diluted share, compared to net income of $2.0 million, or $0.10 net income per diluted share in the same period in the prior year. Non-GAAP adjusted net loss for the fourth quarter was $2.7 million, or $0.14 adjusted net loss per diluted share, compared to adjusted net income of $3.0 million, or $0.15 adjusted net income per diluted share in the same period in the prior year. Non-GAAP adjusted EBITDA for the fourth quarter was $2.8 million, compared to $5.4 million in the same period in the prior year.

    Click here to read the full press release.

    medical-device-investingfinancial-results
    The Conversation (0)

    Go Deeper

    AI Powered

    Viemed Healthcare Announces First Quarter 2021 Financial Results

    Spectral Announces Third Quarter Results

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cardiex Limited

    Cardiex Limited (CDX:AU)
    CDX:AU

    Cleo Diagnostics

    Cleo Diagnostics (COV:AU)
    COV:AU

    Applied UV

    Applied UV (AUVI:NSD)
    AUVI:NSD

    Avricore Health

    Avricore Health (AVCR:CC)
    AVCR:CC
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES